These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

571 related items for PubMed ID: 19327900

  • 1. Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma.
    Morota M, Gomi K, Kozuka T, Chin K, Matsuura M, Oguchi M, Ito H, Yamashita T.
    Int J Radiat Oncol Biol Phys; 2009 Sep 01; 75(1):122-8. PubMed ID: 19327900
    [Abstract] [Full Text] [Related]

  • 2. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus.
    Ishikura S, Nihei K, Ohtsu A, Boku N, Hironaka S, Mera K, Muto M, Ogino T, Yoshida S.
    J Clin Oncol; 2003 Jul 15; 21(14):2697-702. PubMed ID: 12860946
    [Abstract] [Full Text] [Related]

  • 3. Concurrent chemoradiotherapy for locally advanced esophageal cancer--a pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil.
    Hsu CH, Yeh KH, Lui LT, Lee YC, Bu CF, Wang HP, Lin JT, Cheng AL.
    Anticancer Res; 1999 Jul 15; 19(5C):4463-7. PubMed ID: 10650793
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma.
    Yamada K, Murakami M, Okamoto Y, Okuno Y, Nakajima T, Kusumi F, Takakuwa H, Matsusue S.
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1106-11. PubMed ID: 16504758
    [Abstract] [Full Text] [Related]

  • 7. Single-institute phase I/II trial of alternating chemoradiotherapy with 5-FU and nedaplatin for esophageal carcinoma.
    Kodaira T, Fuwa N, Kamata M, Furutani K, Tachibana H, Yamazaki T.
    Anticancer Res; 2006 Mar 15; 26(1B):471-8. PubMed ID: 16739307
    [Abstract] [Full Text] [Related]

  • 8. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
    Ishida K, Ando N, Yamamoto S, Ide H, Shinoda M.
    Jpn J Clin Oncol; 2004 Oct 15; 34(10):615-9. PubMed ID: 15591460
    [Abstract] [Full Text] [Related]

  • 9. Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906).
    Kato K, Muro K, Minashi K, Ohtsu A, Ishikura S, Boku N, Takiuchi H, Komatsu Y, Miyata Y, Fukuda H, Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group (JCOG).
    Int J Radiat Oncol Biol Phys; 2011 Nov 01; 81(3):684-90. PubMed ID: 20932658
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of concurrent chemoradiotherapy as a palliative treatment in stage IVB esophageal cancer patients with dysphagia.
    Ikeda E, Kojima T, Kaneko K, Minashi K, Onozawa M, Nihei K, Fuse N, Yano T, Yoshino T, Tahara M, Doi T, Ohtsu A.
    Jpn J Clin Oncol; 2011 Aug 01; 41(8):964-72. PubMed ID: 21742654
    [Abstract] [Full Text] [Related]

  • 11. Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy.
    Zhang Z, Liao Z, Jin J, Ajani J, Chang JY, Jeter M, Guerrero T, Stevens CW, Swisher S, Ho L, Yao J, Allen P, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):656-64. PubMed ID: 15708243
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: a phase III randomized study.
    Zhao KL, Shi XH, Jiang GL, Yao WQ, Guo XM, Wu GD, Zhu LX.
    Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):1014-20. PubMed ID: 15990003
    [Abstract] [Full Text] [Related]

  • 14. Clinical results of definitive chemoradiotherapy for patients with synchronous head and neck squamous cell carcinoma and esophageal cancer.
    Shinoto M, Shioyama Y, Sasaki T, Nakamura K, Ohura H, Toh Y, Higaki Y, Yamaguchi T, Ohnishi K, Atsumi K, Hirata H, Honda H.
    Am J Clin Oncol; 2011 Aug 15; 34(4):362-6. PubMed ID: 20686402
    [Abstract] [Full Text] [Related]

  • 15. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience.
    Salama JK, Mell LK, Schomas DA, Miller RC, Devisetty K, Jani AB, Mundt AJ, Roeske JC, Liauw SL, Chmura SJ.
    J Clin Oncol; 2007 Oct 10; 25(29):4581-6. PubMed ID: 17925552
    [Abstract] [Full Text] [Related]

  • 16. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
    Miyoshi N, Yano M, Takachi K, Kishi K, Noura S, Eguchi H, Yamada T, Miyashiro I, Ohue M, Ohigashi H, Sasaki Y, Ishikawa O, Doki Y, Imaoka S.
    J Surg Oncol; 2009 Apr 01; 99(5):302-6. PubMed ID: 19170110
    [Abstract] [Full Text] [Related]

  • 17. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus.
    Ariga H, Nemoto K, Miyazaki S, Yoshioka T, Ogawa Y, Sakayauchi T, Jingu K, Miyata G, Onodera K, Ichikawa H, Kamei T, Kato S, Ishioka C, Satomi S, Yamada S.
    Int J Radiat Oncol Biol Phys; 2009 Oct 01; 75(2):348-56. PubMed ID: 19735862
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The safety and usefulness of high-dose-rate endoluminal brachytherapy as a boost in the treatment of patients with esophageal cancer with external beam radiation with or without chemotherapy.
    Vuong T, Szego P, David M, Evans M, Parent J, Mayrand S, Corns R, Burtin P, Faria S, Devic S.
    Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):758-64. PubMed ID: 16199311
    [Abstract] [Full Text] [Related]

  • 20. Late toxicity in complete response cases after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
    Kumekawa Y, Kaneko K, Ito H, Kurahashi T, Konishi K, Katagiri A, Yamamoto T, Kuwahara M, Kubota Y, Muramoto T, Mizutani Y, Imawari M.
    J Gastroenterol; 2006 May 01; 41(5):425-32. PubMed ID: 16799883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.